KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 115.1% | 264.5% | – | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 40.5% | 1.3% | -139.6% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -163.8% | -274.3% | -966.4% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -190.3% | -338.4% | -1,104% | – |
| EPS Diluted | -5.13 | -2.04 | -1.75 | -0.69 |
| % Growth | -151.5% | -16.6% | -153.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |